Anaplastic Thyroid Cancer, ATC

Sriplung H, T hyroid, In : Sriplung, Sontipong S, Martin N, et al. Cancer in Thailand Vol III, 1995- 1957 Bangkok Medical Publisher 2003, P.59.

Pasieka J. Anaplastic thyroid cancer. Curr Opin Oncol 2003; 15: 78-83.

Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A Study of 70 cases. Am J Clin Pathol 1985;83:135-58.

Passlor C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC). Langenbecks Arch Surg 1999; 384: 284-293.

Sukthomya V. Technetium pertechnetate imagining in apparent solitary thyroid nodule. Australas Radiol 1985; 29: 223-225.

Kobayashi TK, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 1996; 18: 36-41.

Buzzoni R, Catena L, Cortinovis D, Dognini G, Bajetta E. Integrated therapeutic strategies for ana- plastic thyroid carcinoma. Tumori 2003: 89:544-6.

Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 1998; 31: 823-31.

Rosen I, Asa S, Brierley J. Anaplastic carcinoma of the thyroid gland. In : Clark O, Duh Q, eds. Textbook of Endocrine Surgery. Philadelphia: Saunders, 1997; 127-32.

Nillisson O, Lindeberg J, Zedenius J, Ekman E, Tennvall I, Blomberg H, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World I Surg 1998;22:725.

Obara T, Tanaka R, Okamoto T, Kanbe M, lihara M. Management of anaplastic thyroid carcinoma: current strategic trends in Japan. Thyroidol Clin Exp 1998;10:51.

Kenneth B. Anaplastic thyroid carcinoma: a therapeutic challengs. Semin Surg Oncol 199999;16:64.

Kim J, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicinand radiation therapy. Cancer 1987; 60: 2372-5.

Sugino K, Ito K, Mimura T, Nagahama M. Fukunari N. Kubo A, et al. The important role of operations in the management of anaplastic thyroid carcinoma. A clinicopathologic study of 121 cases. Surgery 2002; 131: 245-8.

Sugitani I, Kasia N, Fujimoto Y, Yananagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World I Surg 2001; 25: 617-22.

Nel C, Van Heerden J, Goeliner J, Gharib H, McConahey W, Taylor W, et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of cases. Mayo Clin Proc 1985; 60:51.

McIver B, Hay ID, Giuffinida Dvorak, Grant C, Thompson G, et al. Anaplastic thyroid carcinoma: a 50 year experience at a single institution. Surgery 2001; 130: 1028-34.

Pienie JP, Muzikansky A, Gaz R, Faquin W, Oft M. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002;9: 57-64.

Levendag PC, De Porre PM, Van Putten WL. Anaplastic carcinoma of the thyroid galnd treated by radiation therapy. Int J Radiat Oncol Biol Phys 1993; 30: 125-8.

Shimaoka K, Parnentier C, De Wys WD, Creech RH, De Conti R. A randomised trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid cancer. Cancer 19885; 56: 2155-66.

Ahuja S, Ernst H. Chemotherapy of thyroid carcinoma. I Endocrinol Invest 1987; 10:303-10.

Ain KB, Egorin MI, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000; 10: 587-94.

Voigt W, Bulankin A, Multer T, Schoeber Grothy A. Hoang-Vu C, et al. Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines. Clin Cancer Res2000; 6: 2087-93.

Heron DE, Karimpour S, Grigsby PW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradio- therapy in two groups. Am I Clin Oncol 2003; 25: 42-6.

Simson WJ, Anaplastic thyroid carcinoma: a new approach. Can J Surg 1980; 23: 25-7.

Tennvall J, Lundell G, Wahlberg P, Bergenfeltz A, Grimelius L, Akerman M, et al. Anaplastic thyroid carcinoma: three protocols combining doxoxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002; 86: 1848-53.

Haigh PI. Ituarte PH. Wu HS. Tresler Posner M, Quivery J, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001; 23: 1252-61.

Segev D, Umbricht C, Zeiger M. Molecular pathogenesis of thyroid cancer. Surg Oncol 2003; 12: 69-90.

Moretti F, Nanni S, Ponteccorvi A. Molecular pathogenesis of thyroid nodules and cancer. Bailieres Best Practical Research. Clin Endocrinol Metab 2000; 14: 517-39.

Fagin JA, Matsuo K, Karmaker A, Chen D, Tang S, Kocffler H, High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993; 91: 179-84.

Baker S, Preisinger A, Jessup J, Paraskeva Markowitz S, Wilson J. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50: 1287-77-102.